Automatic Simulation-
Simulation-Driven Medical
ec
oj
Device Optimization Design and
Pr
Advanced Multiphase Modeling
r ia
Jeongho Kim
ng
Sa
CENTER FOR ADVANCED RESEARCH DESIGN INNOVATION AND OPTIMIZATION OF MEDICAL DEVICES
Outline
Out e
t
ec
• Background
oj
• Hypothesis
Pr
• C
Case St
Study
d 11: PVAD
ia
• Case Study 2: Magnetic Cell Separator
r
ng
• Case Study 3: Mixture Theory
Sa
2
Manual Design Evaluation Process
t
ec
=
oj
Pr
r ia
ng
Manual Design Process Results
Sa
• Time consuming • Produces limited number of designs
• Error prone tasks • Produces questionable design quality
• Engineers spend more time preparing
3
Automated Design Optimization
Optimizer
t
ec
=
oj
Pr
r ia
ng
Sa
Optimizer as a Software Robot Results
• Automates and iterates design process • Increases evaluations
• Engineer defines simulation process • Improves quality
• Engineer defines goals and constraints • Engineers spend more time analyzing
• Saves valuable engineering time
4
t
ec
oj
Case Study 1:
Pr
PediaFlow Ventricular Assist Device
ia
r
ng
Sa
5
Motivation
ot at o
t
ec
Birth to 2 yrs (3 to 15 kg),
oj
A mixed-type turbodynamic pump
Pr
Magnetically levitated rotor
r ia
ng
Sa
6
Magnetically Levitated Miniature Mixed Flow Blood Pump
PERMANENT
MAGNET
t
BEARINGS
ec
ROTOR
oj
SENSOR
Pr
DRIVE COILS
LINE
r ia
FLOW
STRAIGHTENER
MOTOR
ng IMPELLER
Sa
FIELD COILS BLADES
AXIAL
SUSPENSION MAGNETIC
COILS (CLEARANCE) PF3: World’s smallest maglev VAD
GAP
7
Blood Flow Path
IMPELLER STATOR
t
ec
oj
Pr
r ia
ng
Sa
8
Pump
p Design
g Parameters
BLADE CAMBER BLADE
- incidence HEIGHT
- deflection PROFILE
t
HUB PROFILE - shape TAIL PROFILE
ec
NUMBER OF
oj
BLADES
Pr
ROTOR
ia
SPEED BLADE PROFILE
- section
r
ng - taper
- sweep
- height
Sa
ROTOR STATOR - twist
LENGTH LENGTH
JFA 9.13.94
9
“Optimization”
p by
y Trial and Error
t
ec
oj
Pr
ia
r
ng
Sa
10
CFD
C Analysis
a ys s
t
ec
• SST turbulent model
oj
• Newtonian fluid
Pr
r ia
ng
Sa
11
CFD
C Analysis
a ys s
Rotating
g machine design
g using
g ANSYS Turbosystem
y
t
ec
oj
Pr
ia
r
ng
Sa
CFX-Pre: pre-processor
CFX-Solve: solver
CFX-Post: post-processor
12
Elements of (Shape) Optimization
INITIAL
GEOMETRY
Shape Parameters
t
ec
oj
CFD
Simulation
Pr
Flow Field:
ia
- velocity
- pressure
r
- shear stress
ng
Design Objective Function Search Procedure:
Sa
Objectives & Gradient Evaluation Update Parameters
Acceptance
Criteria reject
OPTIMAL
GEOMETRY
14
Parametric Models of
T b
Turbomachinery
hi Blades
Bl d
t
ec
oj
Pr
ia
r
ng
Sa
15
Automated
uto ated Optimization
Opt at o
• Optimizer: Isight (SIMULIA)
• Algorithm: NLPQL
• Objective: Maximize Efficiency
t
ec
• Constraint: Static Head >= 80 mmHg
oj
Pr
• Optimization automatically changes design variables to find the
"best" design satisfying specified criteria.
r ia
ng
Sa
16
Results:
esu ts Hexahedral
e a ed a Mesh
es
t
ec
oj
Pr
ia
Control total number of mesh
Maintain good mesh quality
r
ng
Sa
17
Results:
esu ts Shape
S ape Optimization
Opt at o
t
Initial Blade
ec
oj
Pr
ia
r
ng
Sa
Optimal
p Blade
18
Results:
esu ts St
Streamlines
ea es
Initial Blade
t
ec
oj
Pr
Optimal Blade
r ia
ng
Sa
t
ec
oj
Pr
r ia
ng
Sa
t
2nd 3rd 4th 1st 2nd 3rd 4th
ec
Quarter,, Quarter,, Quarter,, Quarter,, Quarter,, Quarter,, Quarter,,
2010 2010 2010 2011 2011 2011 2011
oj
Blood Damage
Pr
(FDA Nozzle and PVAD)
ia
Gradient-Based Opt.
r
Response Surface Opt. ng
Sa
Multi-Point Opt.
21
Accomplishments
cco p s e ts
Journal papers
• Ki J.,
Kim, J Antaki,
A t ki J.,
J Simulation-Based
Si l ti B dAAutomatic
t ti O
Optimization
ti i ti off th
the PediaFlowTM
P di Fl TM VAD,
VAD ini
preparation.
t
• JF Antaki1, MR Ricci, JE Verkaik, ST Snyder, TM Maul, J Kim, D Paden, BE Paden, HS
ec
Borovetz, PediaFlow™ Maglev Ventricular Assist Device: A Prescriptive Design Approach,
Cardiovascular Engineering Technology 1(1), 2010
oj
Pr
Conference abstracts and proceedings
• Kim J
Kim, J., Antaki,
Antaki J.,
J Simulation-Based
Simulation Based Automatic Optimization of the PediaFlowTM VAD. VAD
NIH-FDA-NSF Workshop 2010.
ia
• Kim, J., Antaki, J., Simulation-based Design and Optimization of the PediaFlow VAD. NIH-
r
FDA-NSF Workshop 2009. ng
• Shu, F., Verkaik, J., Snyder, S., Paden, D., Kim, J., Antaki, J., Ventricular Assist Device for
Toddlers with Hybrid Magnetic-Mechanical Bearings. ASAIO Abstracts, 2009. 55(2):p.147.
Sa
• Kim, J., Hund, S., Daly, A., Kameneva, M, Antaki, J., Eulerian Method for Numerical
y in PediaFlow VAD. 5th IFAO Proceedings,
Prediction of Hemolysis g , 2009. 5:p.59.
p
• Kim, J., Antaki, J., Computational Fluid Dynamic Shape Optimization of the PediaFlowTM
VAD. ASAIO Abstracts, 2009. 55(2):p.155.
P
Pumpkin
ki PVAD quarterly
t l reports
t (April
(A il 2010,
2010 July
J l 2010)
22
t
ec
oj
Case Study 2:
Pr
Magnetic Cell Separator
ia
r
ng
Sa
23
mPhoresisTM
M
Magnetic
ti CCell
ll S
Separator
t
• A dialysis
dialysis-like
like device that separate malaria infected
RBCs from the blood using magnetic field.
t
ec
Healthy Red Blood Cell
oj
Pr
r ia
ng
Sa
t
ec
MAGNET
oj
Pr
ria
ng
Sa
COMPUTATIONAL DOMAIN
25
Methods:
et ods Automated
uto ated Design
es g
t
ec
• Constraint: 99% Beads Captured
p
oj
• Optimizer: Isight (SIMULIA)
Pr
• Algorithm: NLPQL
r ia
ng
Sa
26
Results:
esu ts Bead
ead Trajectories
ajecto es
t
ec
1 cc/min
oj
Pr
ia
Magnetic Particles (Spherotech, Inc.)
r
- Diameter of 0.3 micron ng
- Mass
M off 1
1.8378e-017
8378 017 kkg
- Susceptibility of 0.26
5 cc/min
Sa
27
Results: Automatic Optimization
p
t
a starting point.
ec
• Need different initial points to find a best optimal
oj
point.
Pr
ia
Minimize Length Side Bounds Initial Optimal Initial Optimal
r
flow rate, cc/min ng
1 to 10 5 1 10 9
height, micron 50 to 300 200 50 300 50
Sa
pitch, micron 100 to 400 200 100 400 100
length, mm 65.4 0.7 927.6 6.9
Iteration 29 19
28
Time
e Table
ab e
t
2nd 3rd 4th 1st 2nd 3rd 4th
ec
Quarter,, Quarter,, Quarter,, Quarter,, Quarter,, Quarter,, Quarter,,
2010 2010 2010 2011 2011 2011 2011
oj
Magnetic Particle
Pr
Dynamics
ia
Lagrangian-Eulerian
r
Mixture Theory ng
Sa
Design Optimization
29
Acomplishments
co p s e ts
Journal papers
• Kim, J., et al., Magnetic particle Dynamics, in
t
ec
manuscript.
manuscript
oj
Pr
Conference abstracts and proceedings
ria
• Kim, J., Gandini, A., Antaki, J., Numerical
ng
Study of Magnetic Field Separator to Remove
Sa
30
t
ec
oj
Case Study 3:
Pr
Developing an Advanced Multiphase Model:
ia
r
Mixture Theory
ng y
Sa
31
Blood
ood Properties
ope t es
• Plasma
– occupies 55-60% of total blood volume
t
ec
• RBCs RBC
oj
DEPLETION
– 40-45% of blood volume ZONE
Pr
– 8-10
8 10 μm diameter
ia
– biconcave discoids
r
ng
– aggregation and deformability
Sa
– RBC tumbling
• White
Whit bl
blood
d cells
ll andd Pl
Platelets
t l t
– only contain 5% by volume Zhao et al.
– important
i t t roles
l in
i immunity
i it and
d hematostasis
h t t i
32
Microscopic Characteristics in
Bl
Blood
d Fl
Flow
• Microhemorheology
– Shear thinning, Fahraeus effect, Fahraeus-Lindqvist
t
ec
effect, Plasma skimming, g Platelet margination,
g etc.
– Device-related micro-hemorheological study is
oj
lacking.
Pr
• Single Phase Model
ia
– cannot predict the concentration profile of blood cells
r
ng
(phase separation)
Sa
– is invalid at micro scale.
• There is no reliable hemorheological model that can
predict hemodynamics for blood flow in blood contacting
devices.
33
Multiphase Modeling:
Mi t
Mixture Theory
Th
• the Theory of Interacting Continua
• based on the ideas of diffusion proposed by Fick
t
ec
• a homogenization approach
oj
– each component is regarded as a single continuum
Pr
and at each instant of time, every point in space is
considered to be occupied by a particle belonging to
ia
each component of the mixture.
r
ng
• The foundation of the theory is given in books by
Truesdell (1984); Dobran (1991) and Rajagopal and Tao
Sa
(1995).
• Johnson et al (1991) and Massoudi et al. (1999) have
formulated a two-phase flow theory based on this mixture
theory
theory.
34
Benefits
e e ts oof tthe
e Mixture
tu e Theory
eo y
t
ec
– velocity field of RBCs and plasma
oj
Pr
– co
concentration
ce a o field edo
of RBCs
Cs aand
dpplasma
as a
ia
• Can be applied to physiological
r
ng
Hematocrit (40
(40~50%)
50%)
Sa
t
ec
x1 χ1 ( X1 , t),
t) and x2 = χ 2 ( X2 , t).
oj
• The kinematical quantities
Pr
associated with these motions are
ia
d1 χ1 d2 χ 2 d1 v1
r
v1 = ; v2 = , a1 =
ng
dt dt dt
Massoudi and Rao, 2001
Sa
d2 v2 v1 v2
a2 = , L1 = , L2 = ,
dt x1 x2
1 1 1 1
D1 = (L1 + L1T ), D2 = (L 2 + L T2 ), W1 (L1 LT 1 ), W2 (L 2 LT 2 )
2 2 2 2
36
A brief review of Mixture Theory,
cont’
t’
t
ec
ρ1 = ρ10 , ρ2 = ρ20,
oj
Pr
– ρ10 is the pure density of the component
ia
1, ρ2 is the pure density of component 2.
r
ng
– ν is the volume fraction of the component
Sa
1, and φ is the volume fraction of
component 2 2.
– For a saturated mixture φ= 1 - ν.
37
A brief review of Mixture Theory,
cont’
t’
• The mixture density
density, ρm and the mean velocity vm of
the mixture are defined
t
ec
m = 1 + 2, ρm v m = ρ1 v1 + ρ2 v 2.
oj
• The individual stress tensors
Pr
T1 (1 )Tf T2 Ts
ia
• A mixture stress tensor
r
ng
Tm T1 T2
Sa
38
A brief review of Mixture Theory,
cont’
t’
Conservation of Conservation of
Mass Linear Momentum
t
ec
Phase 1:
Ph 1 1 D1v1 = div +
+ div ( 1v1) = 0 1 T1 1b1 + fI
oj
Plasma t Dt
Pr
Phase 2: 2 D 2 v 2 = div
+ div ( 2 v 2) = 0 2 T 2 + 2b 2 - f I
ia
RBC t Dt
r
ng
Constitutive Equations
Sa
39
Constitutive Equations
q for Plasma
t
ec
oj
T1 = [ - p(1 - ) + λ (1 - )tr D1 ] I + 2 (1 - )D1
Pr
ia
• p is the fluid pressure, μ is the viscosity,
r
ng
D1 is the symmetric part of the velocity
Sa
t
ec
type fluid.
oj
T2 f ( , , D2 , D2 )
2
Pr
ia
T2 β o β1 β 2 trD 2 I β 3 D 2 β 4 β 5 D 2
2
r
ng
Sa
• β0 is similar to pressure
t
• β2 corresponds to the second coefficient
ec
of viscosity
oj
Pr
• β1 and β4 are the material parameters
ia
connected with the distribution of the
r
ng
RBCs
RBC
Sa
• β3 is the viscosityy
• β5 is similar to the cross-viscosity of a
Reiner Rivlin fluid
Reiner-Rivlin fluid.
42
Constitutive Equation
f RBC Ph
for Phase, cont’
t’
• β0 is similar to pressure
t
• β2 corresponds to the second coefficient
ec
of viscosity
oj
Pr
• β1 and β4 are the material parameters
ia
connected with the distribution of the
r
ng
RBCs
RBC
Sa
• β3 is the viscosityy
• β5 is similar to the cross-viscosity of a
Reiner Rivlin fluid
Reiner-Rivlin fluid.
43
Constitutive Equation
f RBC Ph
for Phase, cont’
t’
• The viscous effects (β3) is assumed to be
predominate over the effects of the gradient
t
ec
of RBC volume fraction,
fraction the second
oj
coefficient of viscosity and the normal
Pr
stresses.
stresses
ia
• β1, β2, β4, and β5 are negligible.
r
ng
• The stress tensor for the RBCs reduces to the
Sa
structure.
T2 0I β3D2
44
Constitutive Equation
f RBC Ph
for Phase, cont’
t’
• β0 and β3 are given by Massoudi and Antaki Antaki,
(2008) 10000
t
ec
1000
p ( ) ( 2
)
oj
0 3
sity (cP) 30
Pr
100
adopting a shear-dependent viscosity for the
viscos
ia
RBC phase,10
proposed by Yeleswarapu et al.
r
ng
1
Sa
1 ln(1 Shear
) Rate (1/s)
1.00E-06
1.00E-04 1.00E-02 1.00E+00 1.00E+02 1.00E+04
3 ( ) ( ( 0 )
1 Model
Present
)( 2 ) [2tr (D 22 )]1/ 2
Experiment (Chien et al. Science 1967)
45
Constitutive Equation
ffor IInteraction
nteraction
t ti Forces
F
t
ec
1990). DIFFUSION
oj
DRAG
Pr
FI = A1 grad φ + A 2 F (φ)( v 2 - v 1 )
r ia
+ A 3 φ(2 tr D12 )-1/4 D1 ( v 2 - v 1 )
ng
A4 φ(W2 W1 )( v 2 - v 1 ) A5 a vm
Sa
t
ec
• The remaining coefficients have not
oj
Pr
been extensively studied for general
ia
two-component flows.
r
– Need e
ng
experiments
periments for 1
1-D
D Mi
Mixture
t re Theor
Theory
Sa
• FVM-based
FVM based open source code
t
• C++
ec
oj
• Linux environment
Pr
• N bl
No blackkbbox
ia
• p g a new flow
Suitable for developing
r
ng
model
Sa
48
Time
e Table
ab e
t
2nd 3rd 4th 1st 2nd 3rd 4th
ec
Quarter,, Quarter,, Quarter,, Quarter,, Quarter,, Quarter,, Quarter,,
2010 2010 2010 2011 2011 2011 2011
oj
1D Mixture Model
Pr
(Five Sub-Studies)
2D/3D Mixture Model
ia
(Expansion Channel,
Exotic Channel)
r
Design Optimization
ng
Sa
49
Accomplishments
cco p s e ts
Journal papers
• Massoudi, M., Kim, J., Hund, S., Antaki, J., A
t
ec
Mixture Theory formulation for Blood Flow
Flow, in
oj
manuscript
Pr
ia
Conference abstracts and proceedings
r
ng
• Massoudi, M., Kim, J., Hund, S., Antaki, J., A
Sa
50
Acknowledgements
c o edge e ts
• Dr. Antaki
t
• Dr. Massoudi
ec
oj
• Dr. Kameneva
Pr
• Dr Gandini
Dr.
ia
• Lab mates
r
ng
Sa
Thanks for your time!
Questions?
Q
51